Annual D&A:
$79.00K+$6000.00(+8.22%)Summary
- As of today, SPRY annual D&A is $79.00 thousand, with the most recent change of +$6000.00 (+8.22%) on December 31, 2024.
- During the last 3 years, SPRY annual D&A has fallen by -$134.00 thousand (-62.91%).
- SPRY annual D&A is now -95.38% below its all-time high of $1.71 million, reached on December 1, 2020.
Performance
SPRY Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$391.00K+$112.00K(+40.14%)Summary
- As of today, SPRY quarterly D&A is $391.00 thousand, with the most recent change of +$112.00 thousand (+40.14%) on September 30, 2025.
- Over the past year, SPRY quarterly D&A has increased by +$370.00 thousand (+1761.90%).
- SPRY quarterly D&A is now -27.73% below its all-time high of $541.00 thousand, reached on September 1, 2021.
Performance
SPRY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$979.00K+$370.00K(+60.76%)Summary
- As of today, SPRY TTM D&A is $979.00 thousand, with the most recent change of +$370.00 thousand (+60.76%) on September 30, 2025.
- Over the past year, SPRY TTM D&A has increased by +$917.00 thousand (+1479.03%).
- SPRY TTM D&A is now -49.25% below its all-time high of $1.93 million, reached on December 1, 2021.
Performance
SPRY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SPRY Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.2% | +1761.9% | +1479.0% |
| 3Y3 Years | -62.9% | +5485.7% | +117.6% |
| 5Y5 Years | -94.9% | - | - |
SPRY Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -75.2% | +8.2% | at high | +5485.7% | at high | +9890.0% |
| 5Y | 5-Year | -95.4% | +8.2% | -27.7% | +1156.8% | -49.3% | +9890.0% |
| All-Time | All-Time | -95.4% | +8.2% | -27.7% | +1156.8% | -49.3% | +9890.0% |
SPRY Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $391.00K(+40.1%) | $979.00K(+60.8%) |
| Jun 2025 | - | $279.00K(-0.4%) | $609.00K(+75.0%) |
| Mar 2025 | - | $280.00K(+865.5%) | $348.00K(+340.5%) |
| Dec 2024 | $79.00K(+8.2%) | $29.00K(+38.1%) | $79.00K(+27.4%) |
| Sep 2024 | - | $21.00K(+16.7%) | $62.00K(0.0%) |
| Jun 2024 | - | $18.00K(+63.6%) | $62.00K(-3.1%) |
| Mar 2024 | - | $11.00K(-8.3%) | $64.00K(-12.3%) |
| Dec 2023 | $73.00K(-77.1%) | $12.00K(-42.9%) | $73.00K(+19.7%) |
| Sep 2023 | - | $21.00K(+5.0%) | $61.00K(+29.8%) |
| Jun 2023 | - | $20.00K(0.0%) | $47.00K(+570.0%) |
| Mar 2023 | - | $20.00K(+185.7%) | -$10.00K(-102.2%) |
| Dec 2022 | $319.00K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $7000.00(+118.9%) | $450.00K(-54.3%) |
| Jun 2022 | - | -$37.00K(-174.0%) | $984.00K(-35.0%) |
| Mar 2022 | - | $50.00K(-88.4%) | $1.51M(-21.6%) |
| Dec 2021 | $213.00K(-87.5%) | - | - |
| Dec 2021 | - | $430.00K(-20.5%) | $1.93M(+28.7%) |
| Sep 2021 | - | $541.00K(+10.0%) | $1.50M(+56.5%) |
| Jun 2021 | - | $492.00K(+5.6%) | $958.00K(+10.2%) |
| Mar 2021 | - | $466.00K(+15.6%) | $869.00K(+8.1%) |
| Dec 2020 | $1.71M(+10.6%) | - | - |
| Jun 2020 | - | $403.00K(+0.5%) | $804.00K(+100.5%) |
| Mar 2020 | - | $401.00K | $401.00K |
| Dec 2019 | $1.55M(+8.9%) | - | - |
| Dec 2018 | $1.42M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual D&A?
- What is the all-time high annual D&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM D&A?
- What is the all-time high TTM D&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is ARS Pharmaceuticals, Inc. annual D&A?
The current annual D&A of SPRY is $79.00K
What is the all-time high annual D&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual D&A is $1.71M
What is ARS Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, SPRY annual D&A has changed by +$6000.00 (+8.22%)
What is ARS Pharmaceuticals, Inc. quarterly D&A?
The current quarterly D&A of SPRY is $391.00K
What is the all-time high quarterly D&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly D&A is $541.00K
What is ARS Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, SPRY quarterly D&A has changed by +$370.00K (+1761.90%)
What is ARS Pharmaceuticals, Inc. TTM D&A?
The current TTM D&A of SPRY is $979.00K
What is the all-time high TTM D&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM D&A is $1.93M
What is ARS Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, SPRY TTM D&A has changed by +$917.00K (+1479.03%)